FindTrial
Sign In

Efficacy of Oral Hydration in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Vascular Intervention

Efficacy of Oral Hydration in the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Vascular Intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088759
Enrollment
Unknown
Registered
2024-08-26
Start date
2023-09-02
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Research Foundation of the First Affiliated Hospital of Chongqing Medical University (HLJJ2020-31)

Interventions

Oral hydration group:Water intake =1000ml 3 hours after surgery.
Venous hydration group:Normal saline was injected at 1ml/ (kg·h) for 4 to 5 hours within 6 hours after surgery.

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: (1) Age 18-90 years old; (2) Use non-ionic iodine contrast agent; (3) The method of anesthesia was local anesthesia; (4) Clear awareness, voluntary participation in this study.

Exclusion criteria

Exclusion criteria: (1) Patients with renal insufficiency; (2) Patients with severe heart failure; (3) Allergic to iodine-containing contrast agents; (4) Those who abstain from food and drink; (5) The use of nephrotoxic drugs.

Design outcomes

Primary

MeasureTime frame
The incidence of The incidence of contrast agent nephropathy;—

Secondary

MeasureTime frame
Urine volume;—

Countries

China

Contacts

Public ContactLiping Liu

The First Affiliated Hospital of Chongqing Medical University

840804395@qq.com+86 185 8006 4207

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026